Company news
SKRR Exploration, Inc. news in 2005
SKRR Exploration, Inc.'s news releases, calls and decks from 2005, newest first.
BLP25 Liposome Vaccine phase 2 study interim results indicate no safety concerns with reformulated vaccine
November 17, 2005
Biomira to present at Bio-Europe 2005
November 7, 2005
Biomira Inc. announces results for the period ended September 30, 2005
October 27, 2005
Biomira announces BLP25 Liposome Vaccine Phase 2B data published in Journal of Clinical Oncology
September 23, 2005
Biomira announces change to timetable for BLP25 Liposome Vaccine phase 3 trial
September 23, 2005
Biomira announces completion of enrolment in BLP25 Liposome Vaccine phase 2 safety study
September 13, 2005
Biomira announces PRA International to assist with completion of BLP25 Liposome Vaccine Phase 3 study in non-small cell lung cancer
September 12, 2005
Biomira to present at Bear Stearns 18th Annual Healthcare Conference
September 8, 2005
Biomira Inc. announces 2nd quarter results
July 27, 2005
Biomira retains Financial Dynamics as communications advisor
July 26, 2005
Biomira exercises rights in Prima BioMed Ltd.
July 19, 2005
Biomira to present at 8th International Workshop on Carcinoma-Associated Mucins Conference
July 7, 2005
Biomira's BLP25 Liposome vaccine Phase IIb data subject of presentation at 11th World Conference on Lung Cancer
June 30, 2005
Biomira(R) to present at BIO 2005 business forum
June 17, 2005
Biomira Announces Highlights of Today's Annual General and Special Meeting
May 18, 2005
Updated Survival Results from BLP25 Liposome Vaccine (L-BLP25) Phase IIb Study from Patients with Stage IIIB Non-Small Cell Lung Cancer (NSCLC) Presented
May 16, 2005
Biomira Inc. - Annual General and Special Meeting Webcast - May 18, 2005
May 16, 2005
Biomira to present at Bear Stearns London Healthcare Conference
May 2, 2005
Biomira Inc. announces 1st quarter results
April 28, 2005
Biomira and Merck KGaA commence BLP25 Liposome Vaccine Phase II safety study
April 20, 2005